Evidence map›Paper›PMID 24196711›Full record

ArticleNature2014

Chasing acyl carrier protein through a catalytic cycle of lipid A production.

Ali Masoudi, Christian R H Raetz, Pei Zhou, Charles W Pemble

Abstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 84 citations in OpenAlex.

  1. RSC chemical biology · 2026
    Article
  2. Article
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. mBio · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. DbStRiPs: Database of structural repeats in proteins.Protein science : a publication of the Protein Society · 2022
    Article
  15. Effects ofMicroorganisms · 2021
    Article
  16. Article
  17. Article
  18. Structural Characterization of an ACP fromInternational journal of molecular sciences · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ali MasoudiDepartment of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.
Christian R H Raetz1] Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA [2].
Pei ZhouDepartment of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.
Charles W Pemble1] Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina 27710, USA [2] Duke Macromolecular Crystallography Center, Duke University Medical Center, Durham, North Carolina 27710, USA.
Duke Medical Center · USDuke University Hospital · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
BIOSYNTHESIS AND FUNCTION OF LIPOPOLYSACCHARIDESR01GM051310 · NIGMS · DUKE UNIVERSITY · PI ZHOU, PEI · 1994 to 2013
$8.1M
Structure and Mechanism of LpxC in Lipid A BiosynthesisR01AI055588 · NIAID · DUKE UNIVERSITY · PI ZHOU, PEI · 2003 to 2012
$3.0M
NCI NIH HHS P30 CA014236NIAID NIH HHS AI-055588NIAID NIH HHS R01 AI055588NIGMS NIH HHS GM-51310NIGMS NIH HHS R01 GM051310
6 · The paper itself

Abstract

Acyl carrier protein represents one of the most highly conserved proteins across all domains of life and is nature's way of transporting hydrocarbon chains in vivo. Notably, type II acyl carrier proteins serve as a crucial interaction hub in primary cellular metabolism by communicating transiently between partner enzymes of the numerous biosynthetic pathways. However, the highly transient nature of such interactions and the inherent conformational mobility of acyl carrier protein have stymied previous attempts to visualize structurally acyl carrier protein tied to an overall catalytic cycle. This is essential to understanding a fundamental aspect of cellular metabolism leading to compounds that are not only useful to the cell, but also of therapeutic value. For example, acyl carrier protein is central to the biosynthesis of the lipid A (endotoxin) component of lipopolysaccharides in Gram-negative microorganisms, which is required for their growth and survival, and is an activator of the mammalian host's immune system, thus emerging as an important therapeutic target. During lipid A synthesis (Raetz pathway), acyl carrier protein shuttles acyl intermediates linked to its prosthetic 4'-phosphopantetheine group among four acyltransferases, including LpxD. Here we report the crystal structures of three forms of Escherichia coli acyl carrier protein engaging LpxD, which represent stalled substrate and liberated products along the reaction coordinate. The structures show the intricate interactions at the interface that optimally position acyl carrier protein for acyl delivery and that directly involve the pantetheinyl group. Conformational differences among the stalled acyl carrier proteins provide the molecular basis for the association-dissociation process. An unanticipated conformational shift of 4'-phosphopantetheine groups within the LpxD catalytic chamber shows an unprecedented role of acyl carrier protein in product release.

Indexed as

BiocatalysisAcyl Carrier ProteinAcyltransferasesCrystallography, X-RayEscherichia coliHydrolysisLipid AModels, MolecularProtein BindingProtein Conformationacyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferaseAcyl Carrier ProteinAcyltransferasesLipid A

Identifiers

PMID24196711
PMCPMC3947097
OpenAlexW2090837200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.